Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection

Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm

(2016) M. W. D. Wren et al.   BRITISH JOURNAL OF BIOMEDICAL SCIENCE

Clostridium difficile Ribotype Does Not Predict Severe Infection

(2012) Seth T. Walk et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: 027, 078, and Others: Going Beyond the Numbers (and Away From the Hypervirulence)

(2012) F. Barbut et al.   CLINICAL INFECTIOUS DISEASES

Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management

(2012) D. W. Eyre et al.   CLINICAL INFECTIOUS DISEASES

Quantitative Fecal Lactoferrin in Toxin-Positive and Toxin-Negative Clostridium difficile Specimens: Table 1

(2012) P. Rocco LaSala et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency

(2011) J. H. Boone et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Economic healthcare costs of Clostridium difficile infection: a systematic review

(2010) S.S. Ghantoji et al.   JOURNAL OF HOSPITAL INFECTION

Diarrhea, Clostridium difficile, and Intestinal Inflammation in Residents of a Long-Term Care Facility

(2010) Laurie Archbald-Pannone et al.   Journal of the American Medical Directors Association

A Nosocomial Outbreak of Norovirus Infection Masquerading asClostridium difficileInfection

(2009) Hoonmo L. Koo et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Clostridium difficile-Associated Disease

(2009) Daniel A. Leffler et al.   GASTROENTEROLOGY

Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile

(2009) S.W. Pawlowski et al.   JOURNAL OF HOSPITAL INFECTION

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study

(2008) Oliver W. Morgan et al.   PLoS One

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES